Watson's biology prospectus suspected of concealing significant matters

Yuncheng has appeared 17 children suspected of vaccination abnormal response of the public Securities newspaper recently on the Yunnan Watson Biotechnology Co., Ltd. (hereinafter referred to as "Watson Biology") series of reports caused a strong response from investors, the market concern for the company also increased markedly. Companies in the prospectus, the market share of the data is questioned by the market, the company has not yet responded to the matter. Behold wave, surging.　　This week, some investors from Kunming, Yunnan, called the material: "Watson's bio-prospectus to conceal the major issues, last July occurred in Shanxi Yuncheng, 17 suspected vaccination abnormal reaction was not disclosed." Such a major event, the reporter dare not "credulous", so the matter was tracked.　　The facts of the investigation are basically in line with those of the explosive material. 17 suspected inoculation abnormalities in Yuncheng City daily sponsored by the "Yuncheng News Network" on the Transport of Urban Health Bureau of Yuncheng Municipal Committee of the Office of the "Jiangxian Wei Zhuang Zhen Guanju Village Li Zhiping reflect the problem of child vaccination" made a special report.　　Jiangxian belongs to Yuncheng, located in the northeastern end of the city. The report, written on August 24, 2009, shows that the Jiangxian CDC July 2, 2009 to 5 years old children in the county to vaccinate against Hib combined vaccine, a total of 4,942 children of school age. This vaccination is the Yuxi Watson Technology Co., Ltd. (the Department of Watson Bio-owned subsidiary) production of "Bombeck" brand vaccine, by the Henan Province Kaifeng Products Co., Ltd. distribution. As of July 25 16 o'clock, Jiangxian found 17 children suspected to be vaccinated against abnormal reaction.　　After the disease-resistant, intracranial pressure and symptomatic treatment, all children were cured and discharged as of July 29. It is worth mentioning that the city Health Bureau, organized by the Group of Experts on the vaccination and clinical manifestations of children in a comprehensive analysis, that "17 cases and vaccination of HIB-linked vaccine without causal relationship." The two main reasons for supporting its identification are: First, the vaccination are qualified manufacturers of the production, and by the national competent authorities to identify qualified, and in the validity of the use of the vaccine supply channel normal, vaccination operation norms; second, the vaccine safety is good, the instruction manual does not cause the adverse reaction of viral encephalitis, also has no related report.　　The number of hospitalized cases caused by this inoculation is viral encephalitis, which belongs to the coincidence case.　　The investigation report was questioned by the media as the investigation deepened, reporters in China Network (www.china.org.cn/www.china.com.cn), which is under the leadership of the State Council's news office, found news reports different from the above-mentioned reports. In the report, published July 30, 2009, entitled "Jiangxian: Multiple abnormal responses after vaccination against children", the above Jiangxian child vaccination incident was more serious than suspected vaccination. Jiangxian Disease Control Center in charge of the director of an interview in China Network Reporter said: "This total of more than 4,000 children 3 months to 5 years old child vaccinated with Hib vaccine." From the beginning of the vaccination to July 15 within the county government organization experts to troubleshoot a total of 17 cases in line with the vaccinationFever symptoms, and immediately arrange hospitalization. There were 1 deaths in children, but the diagnosis was not related to vaccination. "However, the city Health Bureau of Transport, Yuncheng CDC, suspected prevention of abnormal response to the investigation and diagnosis Expert group, such as the establishment of the joint investigation team issued by the vaccination of Haemophilus influenzae type B suspected vaccination after the abnormal reaction of the investigation report (hereinafter referred to as" investigation Report ") by the Chinese network reporters questioned:" The final ' investigation report ' of the relevant departments determines: The vaccine is safe, the supply channel is normal, the operation is standard, and the case has no causal relationship with the vaccination of Hib vaccine. But why did the report not stamp the relevant department? How can the evidence report without the official seal represent the credibility of the Government department? "The prospectus does not mention this. Hib vaccine is the" B-type Haemophilus influenzae combination vaccine "abbreviation, the vaccine is Watson's biological currently in the sale of two vaccine products, and occupies an absolute weight.　　2007, 2008, 2009 and 2010 1-June, Hib sales accounted for 100%, 100%, 82.76% and 81.23% of Watson's production of bio-vaccine products. However, there is no trace of such a significant event in the Watson Biology prospectus.　　In the company's "Prospectus" P158 page "recent products or due to logistics reasons leading to acceptance of nonconforming product return" only described in October 2008 in Shandong was reported a suspected vaccination company Hib vaccine product abnormal reaction. "It only mentioned one case of Shandong in 2008 years. No drug is possible for everyone, 1 per thousand, one out of 10,000. Therefore, there is a situation where the drug is unsafe, but the product quality is no problem. "The source said:" I consulted a sponsor friend, this situation according to the provisions must be disclosed, which is concealed. "On the afternoon of November 2, the reporter called Watson biology to the public contact telephone 0871-8312779.　　However, the accident happened: "Welcome to the Yunnan Watson Biotechnology Co., Ltd., the phone is being transferred, please wait a moment" after recording the voice, there is a "drip" fax in the receiver.　　Immediately, the reporter called The Watson Biology "prospectus" to stay in the sponsors Ping an securities limited liability company telephone, no answer.　　The Volkswagen Securities Journal will continue to pay attention to the matter. Reporter Yechai